NCT04914182

Brief Summary

Scenario: spontaneous perineal laceration is an injury to the tissue in the perineum region, which can occur during vaginal delivery. The lesion can be classified into four degrees, according to the structures affected, with degrees one and two being more common. Some consequences may arise due to lacerations, such as perineal pain, genito-pelvic pain, in addition to infection, and dehiscence of the lesion, which may last up to one year after delivery. A laser is a form of non-ionizing radiation and when used in the repair process it is capable of generating analgesic, anti-inflammatory, and healing effects. Low-level laser treatment has been used in several areas, promoting cellular and vascular responses capable of accelerating the repair of injured tissue, in addition to pain relief and consequently capable of improving patients' quality of life. Objective: To determine the effects of low-power laser on the acceleration of the healing process and pain relief in primiparous women who had a spontaneous perineal tear, grade one and two, during normal delivery. Methods: a pilot randomized clinical trial will be carried out. Two groups will be divided randomly, one group will receive the application of the laser, and the second group the laser "sham". Data collection will be carried out at the LAbor and delivery rooms of the Instituto de Medicina Integral Prof. Fernando Figueira (IMIP). Primiparous women who had a spontaneous perineal tear, grades one and two, over 18 years of age or younger who are in charge, with a full-term pregnancy, single fetus, cephalic presentation, and who have been admitted to labor at the ANC will be included, excluding patients who are transferred to another sector, those that evolve to a cesarean section or need episiotomy or curettage and, in addition, the presence of infection during childbirth assistance, postpartum hemorrhage and suspected or diagnosed COVID-19. The laser will be applied at three predetermined moments: six hours, 24, and 48 hours after delivery. To evaluate the healing process a REEDA scale and a Peri-rule will be used. The assessment of pain intensity will be through the Visual Analogue Scale (VAS). Ethical Aspects: the research will be submitted to the IMIP Research Ethics Committee and data collection will begin after its approval. All data will be kept confidential and confidential, the participant will be asked to sign the Informed Consent Form before beginning any procedure.

Trial Health

33
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Trial recruitment is currently suspended
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 30, 2021

Completed
4 days until next milestone

Study Start

First participant enrolled

June 3, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 4, 2021

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2024

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2024

Completed
Last Updated

May 31, 2023

Status Verified

May 1, 2023

Enrollment Period

2.7 years

First QC Date

May 30, 2021

Last Update Submit

May 29, 2023

Conditions

Keywords

perineallaserpainVisual Analog Scale

Outcome Measures

Primary Outcomes (5)

  • SIZE OF LACERATION 6 hours after delivery

    Size in centimeters of the perineal laceration, measured by the PERI-RULE 6 hours after delivery

    6 HOURS

  • SIZE OF LACERATION 6 hours after delivery

    Size in centimeters of the perineal laceration, measured by the PERI-RULE 24 hours after delivery

    24 hours after delivery

  • SIZE OF LACERATION 6 hours after delivery

    Size in centimeters of the perineal laceration, measured by the PERI-RULE 48 hours after delivery

    48 hours after delivery

  • SIZE OF LACERATION AFTER ONE WEEK

    Size in centimeters of the perineal laceration, measured by the PERI-RULE one week after delivery

    1 WEEK

  • SIZE OF LACERATION AFTER 42 DAYS

    Size in centimeters of the perineal laceration, measured by the PERI-RULE after 42 days of delivery

    42 DAYS

Secondary Outcomes (35)

  • REDNESS AFTER 5 HOURS

    6 hours after delivery

  • REDNESS AFTER 24 HOURS

    24 hours after delivery

  • REDNESS AFTER 48 HOURS

    48 hours after delivery

  • REDNESS AFTER 7 DAYS

    7 days

  • REDNESS AFTER 42 DAYS

    42 days

  • +30 more secondary outcomes

Study Arms (2)

LASER

EXPERIMENTAL

In the intervention group, the laser will be applied to the points of the edges of the lesion, with a distance of one centimeter between them. The laser will be applied in a punctual way, in points on the edges of the lesion site, with a distance of one centimeter between them. This application will take place three times: six hours after delivery, 24 and 48 hours after delivery.

Radiation: LASER

CONTROL

SHAM COMPARATOR

In the control group, the sham laser will be applied the exact same way as the real laser, to the points of the edges of the lesion, with a distance of one centimeter between them. The sham laser will be applied in a punctual way, in points on the edges of the lesion site, with a distance of one centimeter between them. This application will take place three times: six hours after delivery, 24 and 48 hours after delivery.

Radiation: CONTROL

Interventions

LASERRADIATION

Laser will be applied in specific points for perineal lacerations.

LASER
CONTROLRADIATION

A control group of sham laser will create for the patients the impression that laser is being played, with the lights of the instrument of "on mode" turned on, without biological effects.

CONTROL

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Deliveries Assisted at the labor and delivery rooms (low risk)
  • Spontaneous perineal laceration (grades 1 and 2)
  • Primipara
  • Full-term pregnancy (37 to 41 weeks and six days)
  • Women over the age of 18 or under who are the presence of a responsible party
  • cephalic presentation
  • Single fetus
  • Admitted in labor

You may not qualify if:

  • Transfer to another sector;
  • Performing an episiotomy;
  • Evolution to cesarean section;
  • Need for curettage;
  • Instrumental delivery (use of forceps and vacuum);
  • A patient who had the child referred to another sector;
  • Shoulder dystocia;
  • Change in skin sensitivity;
  • Presence of infection during childbirth care;
  • Postpartum hemorrhage;
  • Suspected or diagnosed with COVID-19

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maternidade Professor Barros Lima

Recife, Pernambuco, 52070-660, Brazil

Location

MeSH Terms

Conditions

Pain

Interventions

Lasers

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Optical DevicesEquipment and SuppliesRadiation Equipment and Supplies

Study Officials

  • Melania M Amorim, PhD

    IMIP

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Control sham: To the patients in the control group a sham control will be applied, corresponding to the device only connected, emitting the signal of being "turned on" but without therapeutic effect. The irradiation time and the number of application points will be the same as for the intervention group. The patient will remain masked, and the investigators that will perform the statistical analysis will be masked until the end of the analysis.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A randomized clinical trial will be conducted, participants will be assigned to the intervention group or the control group in parallel for the duration of the study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Coordinator of the Obstetrical ICU

Study Record Dates

First Submitted

May 30, 2021

First Posted

June 4, 2021

Study Start

June 3, 2021

Primary Completion

February 1, 2024

Study Completion

October 1, 2024

Last Updated

May 31, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations